ArticleInternational journal of molecular sciences2022

Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer.

María Del Mar Noblejas-López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.